Evidence map›Paper›PMID 32352317›Full record

ArticleEnvironmental health perspectives2020

Evaluating the Role of the Steroid and Xenobiotic Receptor (SXR/PXR) in PCB-153 Metabolism and Protection against Associated Adverse Effects during Perinatal and Chronic Exposure in Mice.

Riann Jenay Egusquiza, Maria Elena Ambrosio, Shuyi Gin Wang, Kaelen Marie Kay, Chunyun Zhang, Hans-Joachim Lehmler, Bruce Blumberg

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Pregnane X Receptor and the Gut-Liver Axis: A Recent Update.Drug metabolism and disposition: the biological fate of chemicals · 2022
    Review
  7. Article
  8. Review
  9. Review
  10. Oxidative medicine and cellular longevity · 2021
    Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Riann Jenay EgusquizaDepartment of Pharmaceutical Sciences, University of California, Irvine, California, USA.
Maria Elena AmbrosioDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
Shuyi Gin WangDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
Kaelen Marie KayDepartment of Developmental and Cell Biology, University of California, Irvine, California, USA.
Chunyun ZhangDepartment of Occupational and Environmental Health, University of Iowa, Iowa City, Iowa, USA.
Hans-Joachim LehmlerDepartment of Occupational and Environmental Health, University of Iowa, Iowa City, Iowa, USA.
Bruce BlumbergDepartment of Pharmaceutical Sciences, University of California, Irvine, California, USA.
University of California, Irvine · USUniversity of Iowa · US

Funding

Training CoreP42ES013661 · NIEHS · UNIVERSITY OF IOWA · PI Rachel Frances Marek · 2006 to 2026
$60.3M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Endocrine disrupter modulation of SXR in development and lymphomagenesisR01ES021832 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLUMBERG, BRUCE · 2013 to 2017
$1.9M
NIEHS NIH HHS P30 ES005605NIEHS NIH HHS P42 ES013661NIEHS NIH HHS R01 ES021832
6 · The paper itself

Abstract

backgroundPolychlorinated biphenyls (PCBs) are environmental toxicants; PCB exposure has been associated with adverse effects on wildlife and humans. However, the mechanisms underlying these adverse effects are not fully understood. The steroid and xenobiotic receptor [SXR; also known as the pregnane X receptor (PXR) and formally known as NR1I2] is a nuclear hormone receptor that regulates inducible metabolism of drugs and xenobiotics and is activated or inhibited by various PCB congeners.

objectivesThe aim of this study was to investigate the effects of exposure to PCB-153, the most prevalent PCB congener in human tissues, on SXR knockout mice (SXRKO) and to elucidate the role of SXR in PCB-153 metabolism and promotion of its harmful effects.

methodsWild-type (WT) and SXRKO mice were chronically or perinatally exposed to a low dose (

resultsSXRKO mice perinatally exposed to PCB-153 displayed elevated oxidative stress, symptoms of hemolytic anemia, and premature death. Transcriptomal analysis revealed that expression of genes involved in metabolic processes was altered in SXRKO mice. Elevated levels of the PCB-153 metabolite, 3-OH-PCB-153, were found in exposed SXRKO mice compared to exposed WT mice. Blood hemoglobin (HGB) levels were lower throughout the lifespan, and the occurrence of intestinal tumors was larger in SXRKO mice chronically exposed to PCB-153 compared to vehicle and WT controls. DISCUSSION: Our results suggest that altered metabolism induced by SXR loss of function resulted in the accumulation of hydroxylated metabolites upon exposure to PCB-153, leading to oxidative stress, hemolytic anemia, and tumor development in a mouse model. These results support a major role for SXR/PXR in protection against xenobiotic-induced oxidative stress by maintaining proper metabolism in response to PCB-153 exposure. This role of SXR could be generally applicable to other environmental toxicants as well as pharmaceutical drugs. https://doi.org/10.1289/EHP6262.

Indexed as

AnimalsEnvironmental PollutantsFemaleMaleMaternal ExposureMiceMice, KnockoutPolychlorinated BiphenylsPregnane X ReceptorProtective Agents2,4,5,2',4',5'-hexachlorobiphenylEnvironmental PollutantsPolychlorinated BiphenylsPregnane X ReceptorProtective Agents

Identifiers

PMID32352317
PMCPMC7228131
OpenAlexW3023032491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.